RT Journal Article
SR Electronic
T1 711 Development of oncolytic adenovirus Ad5/3-E2F-D24-hTNFa-IRES-hIL2 (TILT-123) for the treatment of solid tumours – from preclinical testing to phase I clinical trials
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP A806
OP A806
DO 10.1136/jitc-2023-SITC2023.0711
VO 11
IS Suppl 1
A1 Clubb, James
A1 Cervera-Carrascon, Victor
A1 Peltola, Katriina
A1 Alanko, Tuomo
A1 Korpisaari, Riitta
A1 Jaakkola, Marjut
A1 Sormunen, Jorma
A1 Kononen, Juha
A1 Santos, Joao Manuel
A1 Pakola, Santeri A
A1 Jirovec, Elise
A1 Kudling, Tatiana
A1 Haybout, Lyna
A1 Quixabeira, Dafne CA
A1 Kistler, Claudia
A1 Havunen, Riikka
A1 Sorsa, Suvi
A1 Hemminki, Akseli
YR 2023
UL http://jitc.bmj.com/content/11/Suppl_1/A806.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.